miR-485-5p suppresses Schwann cell proliferation and myelination by targeting cdc42 and Rac1
miR-485-5p suppresses Schwann cell proliferation and myelination by targeting cdc42 and Rac1
复制标题
DOI:
10.1016/j.yexcr.2019.111803
复制
发表时间:
2020-03-01
影响因子:
3.7
通讯作者:
Wu, Guangzhi
中科院分区:
文献类型:
--
作者:
Zhang, Zhan;Li, Xuyang;Wu, Guangzhi
Schwann cells, a crucial element in peripheral nervous system, play important roles after peripheral nerve injury. In recent years, the role of miR-485-5p has been discovered in neurological diseases. However, the involvement of miR-485-5p and peripheral nerve injury remains unknown. Mice were subjected to sciatic nerve crush to mimic peripheral nerve injury and the expression of miR-485-5p was detected in sciatic nerve stumps by realtime PCR. BrdU assay was used to analyze the proliferation of Schwann cells after transfecdon with miR-485-5p mimic and miR-485-5p inhibitor. The effect of miR-485-5p on Schwann cell myelination was determined by evaluating levels of cyclic adenosine monophosphate (cAMP)-induced myelin-associated proteins, including Krox20 and MBP, as well as the coculture of Schwann cells and dorsal root ganglion (DRG) neurons via immunostaining with anti-MBP antibodies. The regulation mechanism of miR-485-5p was measured by bioinformatics analysis, luciferase reporter assay, and real-time PCR and Western blot. We found miR-485-5p expression was downregulated post nerve injury. miR-485-5p mimic significantly suppressed the proliferation and cAMP-induced expression levels of Krox20 and MBP in Schwann cells. Conversely, miR-485.5p inhibitor promoted these changes in Schwann cells. Also, miR-485-5p inhibitor elevated MBP-positive myelinated fibers. Cdc42 and Racl are targets of miR-485-5p in Schwann cells. Downregulation of cdc42 reversed the effect of miR-485-5p inhibitor on the proliferation of Schwann cells. And reducing Racl expression attenuated the effect of miR-4855p silencing on Schwann cell myelination. In conclusion, this study indicated that miR-485.5p suppressed the proliferation and myelination of Schwann cells via targeting cdc42 and Rac1. Which may provide a novel method for the treatment of peripheral nerve injury.